Deng Y, Yang J, Chen Y, Wang J, et al. Development of a Risk Classifier to Predict Tumor Recurrence and Lenvatinib Benefits in Hepatocellular Carcinoma After Liver Transplantation. Transplant Proc 2022 Dec 13:S0041-1345(22)00770.
PMID: 36522222